Clinical trial
Alfapump® System in the Treatment of Refractory or Recurrent Ascites: a Multicenter Single Arm Within Subject Crossover Design Pivotal Study (the POSEIDON Study)
NCT03973866 is registered in ClinicalTrials.gov with Sequana Medical N.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alfapump® System in the Treatment of Refractory or Recurrent Ascites: a Multicenter Single Arm Within Subject Crossover Design Pivotal Study (the POSEIDON Study)
- Lead sponsor
- Sequana Medical N.V.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 16, 2019
- Completion date
- June 30, 2024
- Enrollment
- 110 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.